ID H7D7A AC CVCL_1T06 SY H7D7-A DR BioSample; SAMN03151769 DR cancercelllines; CVCL_1T06 DR Wikidata; Q54872220 RX PubMed=12619888; RX PubMed=20143388; WW Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx CC Problematic cell line: Contaminated. Shown to be a Hep-G2 derivative (PubMed=12619888; PubMed=20143388). Originally thought to originate from SV40-transformed normal liver cells. CC Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00203. CC Population: Caucasian. CC Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line). CC Derived from site: In situ; Liver; UBERON=UBERON_0002107. ST Source(s): PubMed=12619888 ST Amelogenin: X,Y ST CSF1PO: 10,11 ST D16S539: 12,13 ST D21S11: 29,31 ST D3S1358: 15,16 ST D7S820: 10 ST TH01: 9 ST TPOX: 8,9 ST vWA: 17 DI NCIt; C3728; Hepatoblastoma DI ORDO; Orphanet_449; Hepatoblastoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) HI CVCL_0027 ! Hep-G2 SX Male AG 15Y CA Cancer cell line DT Created: 08-07-15; Last updated: 10-04-25; Version: 20 // RX PubMed=20143388; DOI=10.1002/ijc.25242; RA Capes-Davis, Amanda RA Theodosopoulos, George RA Atkin, Isobel RA Drexler, Hans Gunther RA Kohara, Arihiro RA MacLeod, Roderick A.F. RA Masters, John R.W. RA Nakamura, Yukio RA Reid, Yvonne A. RA Reddel, Roger Robert RA Freshney, Robert Ian RT "Check your cultures! A list of cross-contaminated or misidentified RT cell lines."; RL Int. J. Cancer 127:1-8(2010). // RX PubMed=12619888; DOI=10.1023/A:1021653506123; RA van Pelt, Jos F. RA Decorte, Ronny RA Yap, Paul S.H. RA Fevery, Johan RT "Identification of HepG2 variant cell lines by short tandem repeat RT (STR) analysis."; RL Mol. Cell. Biochem. 243:49-54(2003). //